Figure 2.
HbA1c change from baseline with GKA treatment versus placebo in type 2 diabetes. HbA1c, hemoglobin A1c; GKA, glucokinase activator; ES, effect size; CI, confidential interval.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.